Microchip (MCHP) Officer Sells 15,269 Shares; Receives 485 RSUs

Q: What did the Microchip (MCHP) Form 4 report for Joseph R. Krawczyk II?

The Form 4 reports a disposition of 15,269 shares and a grant of 485 restricted stock units (RSUs) on August 8, 2025.

Q: When do the 485 RSUs granted to the MCHP officer vest?

The RSUs vest in full on August 15, 2026, provided the reporting person remains a service provider through that date.

Q: Was the sale price disclosed for the 15,269 shares sold?

No. The Form 4 does not disclose a sale price for the 15,269 share disposition.

Q: What is the reporting person’s role at Microchip?

The reporting person is listed as Senior Vice President, Worldwide Client Engagement.

Joseph R. Krawczyk II, Senior Vice President, Worldwide Client Engagement at Microchip Technology, reported a disposition and a compensatory award on a Form 4.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Joseph R. Krawczyk II, Senior Vice President, Worldwide Client Engagement at Microchip Technology, reported a disposition and a compensatory award on a Form 4. The filing shows a sale/disposition of 15,269 shares on August 8, 2025; the sale price is not disclosed in the form. The filing also records a grant of 485 restricted stock units (RSUs) on the same date, each converting to one share and shown with a $0 price in the filing. Those RSUs vest in full on August 15, 2026 provided the reporting person remains a service provider, and vested shares will be delivered upon vesting.

Positive

485 restricted stock units granted to the officer, aligning compensation with shareholder value through service-based vesting on August 15, 2026
RSU award shown at $0 in the filing (standard for many equity-based compensation grants)

Negative

Disposition of 15,269 shares by a senior officer was reported without a sale price, limiting transparency about the size and motive of the sale
Form does not disclose post-transaction common stock holdings for the reporting person, reducing clarity on remaining insider exposure

Insights

TL;DR: Officer sold 15,269 shares and received 485 RSUs; sale price not disclosed, RSUs vest in August 2026.

The transaction is a routine insider disclosure combining a disposition and a compensatory award. The sale of 15,269 shares was reported without a price, limiting assessment of cash proceeds or tax-motivated selling. The grant of 485 RSUs aligns compensation with shareholder outcomes via service-based vesting on August 15, 2026. Absent the sale price or broader holding context, the filing alone is insufficient to infer material impact on company valuation.

TL;DR: Filing shows standard officer compensation plus an open-market disposition; no governance red flags in the disclosure itself.

The Form 4 documents a compensatory RSU award and a contemporaneous disposition by a senior officer. The RSU award is fully service-conditioned and will vest on a single date next year, which is typical for retention-focused packages. The absence of a disclosed sale price reduces transparency for investors evaluating insider intent, but the filing contains required disclosures for the transactions reported.

Insider Trade Summary

Grant/Award: 485 shares

Grant/Award 2 txns

Insider Krawczyk Joseph R II

Role SR. VP, WW CLIENT ENGAGEMENT

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	485	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 485 contracts (Direct); Common Stock — 15,269 shares (Direct)

Footnotes (2)

F1. Each restricted stock unit represents a contingent right to receive one share of Microchip Technology Incorporated common stock.
F2. The restricted stock units will vest in full on August 15, 2026 as long as the individual remains a service provider through the vesting date. Vested shares will be delivered to the reporting person upon vest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Microchip (MCHP) Form 4 report for Joseph R. Krawczyk II?

The Form 4 reports a disposition of 15,269 shares and a grant of 485 restricted stock units (RSUs) on August 8, 2025.

When do the 485 RSUs granted to the MCHP officer vest?

The RSUs vest in full on August 15, 2026, provided the reporting person remains a service provider through that date.

Was the sale price disclosed for the 15,269 shares sold?

No. The Form 4 does not disclose a sale price for the 15,269 share disposition.

How many shares will each restricted stock unit convert into?

Each restricted stock unit represents a contingent right to receive one share of Microchip Technology common stock upon vesting.

What is the reporting person’s role at Microchip?

The reporting person is listed as Senior Vice President, Worldwide Client Engagement.

Does the Form 4 indicate if the transactions were pursuant to a trading plan?

The filing content provided does not indicate that the transactions were made pursuant to a 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/12/2025 - 04:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krawczyk Joseph R II

(Last)

(First)

(Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 W CHANDLER BLVD

(Street)

CHANDLER

85224-6199

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SR. VP, WW CLIENT ENGAGEMENT

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								15,269	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	08/08/2025		A		485		⁽²⁾	⁽²⁾	Common Stock	485	$0	485	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Microchip Technology Incorporated common stock.

2. The restricted stock units will vest in full on August 15, 2026 as long as the individual remains a service provider through the vesting date. Vested shares will be delivered to the reporting person upon vest.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Microchip (MCHP) Officer Sells 15,269 Shares; Receives 485 RSUs